» Articles » PMID: 31080747

Contrast-induced Nephropathy in an Animal Model: Evaluation of Novel Biomarkers in Blood and Tissue Samples

Abstract

Identification of novel biomarkers of contrast-induced nephropathy (CIN) that may more accurately detect renal function changes; reflect kidney damage; assist monitoring; and elucidate pathophysiology attract considerable scientific attention nowadays. To evaluate novel biomarkers of nephrotoxicity in blood/tissue samples of a CIN model, 10 New Zealand white rabbits were divided into group 1 (n = 5; iopromide) and group 2 (n = 5; control). Blood was drawn at 0 h (immediately), 24 h and 48 h after contrast medium (CM) administration. Animals were euthanized at 48 h and kidneys were removed. Serum creatinine (sCr)/symmetric-asymmetric dimethylarginine (SDMA-ADMA) levels were measured. CM genotoxic/cytotoxic effect was investigated 48 h post-CM exposure using micronucleus assay in lymphocytes. Cytological examination was conducted using touch preparation technique (TPT). All animals in group 1 developed CIN: mean sCr levels increased by 68.2% within 48 h. Significant SDMA-ADMA level elevation was observed at 0 h and 24 h with insignificant drop at 48 h in group 1, remaining normal in group 2 at all time-points. Significant increase in bi-nucleated cells with micronuclei and micronuclei frequency was detected in group 1. Cytokinesis block proliferation index was reduced insignificantly in group 1. TPT revealed degenerative lesions/inflammation, cell degeneration, abnormal uterine tubular casts and rubella in kidneys of all animals in group 1. Group 2 presented normal cells.

Citing Articles

Effects of iopromide contrast agents on kidney iNOS expression and tubular histopathology alterations.

Pranoto I, Djojodimedjo T, Soebadi M, Rahaju A Narra J. 2025; 4(3):e1227.

PMID: 39816096 PMC: 11731809. DOI: 10.52225/narra.v4i3.1227.


Evaluation of pathways involved in the protective effect of trans sodium crocetinate against contrast-induced nephropathy in rats.

Rajabian F, Razavi B, Mehri S, Amouian S, Rahbardar M, Khajavi Rad A Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39549062 DOI: 10.1007/s00210-024-03600-y.


Biomarkers in Contrast-Induced Acute Kidney Injury: Towards A New Perspective.

Gonzalez-Nicolas M, Gonzalez-Guerrero C, Goicoechea M, Bosca L, Valino-Rivas L, Lazaro A Int J Mol Sci. 2024; 25(6).

PMID: 38542410 PMC: 10970772. DOI: 10.3390/ijms25063438.


Preventive effect and mechanism of compound Danshen dripping pills on contrast-induced nephropathy after percutaneous coronary interventional.

Fu H, Wang L, Ying S, Zhao Z, Zhang P Front Cardiovasc Med. 2023; 10:1211982.

PMID: 38124888 PMC: 10731959. DOI: 10.3389/fcvm.2023.1211982.


The Potential Biotherapeutic Targets of Contrast-Induced Acute Kidney Injury.

Cheng A, Li X Int J Mol Sci. 2023; 24(9).

PMID: 37175958 PMC: 10178966. DOI: 10.3390/ijms24098254.


References
1.
Keaney J, Hannon C, Murray P . Contrast-induced acute kidney injury: how much contrast is safe?. Nephrol Dial Transplant. 2013; 28(6):1376-83. DOI: 10.1093/ndt/gfs602. View

2.
Ramponi S, Grotti A, Morisetti A, Vultaggio S, Lorusso V . Effects of iodinated contrast media on endothelium: An in vitro study. Toxicol In Vitro. 2006; 21(2):191-6. DOI: 10.1016/j.tiv.2006.09.018. View

3.
Diamantis A, Beloukas A, Kalogeraki A, Magiorkinis E . A brief chronicle of cytology: from Janssen to Papanicolaou and beyond. Diagn Cytopathol. 2012; 41(6):555-64. DOI: 10.1002/dc.22887. View

4.
Cochran S, Khodadoust A, Norman A . Cytogenetic effects of contrast material in patients undergoing excretory urography. Radiology. 1980; 136(1):43-6. DOI: 10.1148/radiology.136.1.7384520. View

5.
Romano G, Briguori C, Quintavalle C, Zanca C, Rivera N, Colombo A . Contrast agents and renal cell apoptosis. Eur Heart J. 2008; 29(20):2569-76. DOI: 10.1093/eurheartj/ehn197. View